Euglena Co Ltd
TSE:2931
Euglena Co Ltd
Net Income (Common)
Euglena Co Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Euglena Co Ltd
TSE:2931
|
Net Income (Common)
-¥2.7B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
Shiseido Co Ltd
TSE:4911
|
Net Income (Common)
¥21.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Net Income (Common)
¥30.9B
|
CAGR 3-Years
32%
|
CAGR 5-Years
25%
|
CAGR 10-Years
13%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Net Income (Common)
¥9.7B
|
CAGR 3-Years
28%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
Kao Corp
TSE:4452
|
Net Income (Common)
¥43.9B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-4%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Net Income (Common)
¥20.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
7%
|
See Also
What is Euglena Co Ltd's Net Income (Common)?
Net Income (Common)
-2.7B
JPY
Based on the financial report for Dec 31, 2023, Euglena Co Ltd's Net Income (Common) amounts to -2.7B JPY.
What is Euglena Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
18%
Over the last year, the Net Income (Common) growth was 1%. The average annual Net Income (Common) growth rates for Euglena Co Ltd have been -18% over the past three years , 18% over the past five years .